| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 140-31-8 | N-氨乙基哌嗪; 氨乙基哌嗪; 氨基乙基对二氮己环 | N-Aminoethylpiperazine; 1-(2-Aminoethyl)piperazine; 1-Piperazineethanamine; 2-Piperazin-1-ylethylamine; AEP |  | C6H15N3 | 详情 | 供应商 |
| 59703-84-3 | 哌拉西林钠; (2S,5R,6R)-3,3-二甲基-6-[(4-乙基-2,3-二氧代-1-哌嗪甲酰氨基)苯乙酰氨基]-7-氧代-4-硫杂-1-氮 | Piperacillin sodium salt; [2S-[2alpha,5alpha,6beta(S*)]]-6-[[[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid monosodium salt |  | C23H26N5NaO7S | 详情 | 供应商 |
| 61477-96-1 | 哌拉西林; 氧哌嗪青霉素酸; (2S,5R,6R)-3,3-二甲基-6-[(4-乙基-2,3-二氧代-1-哌嗪甲酰氨基)苯乙酰氨基]-7-氧? | Pipracil; (2S,5R,6R)-6-[[(2R)-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Piperacillin |  | C23H27N5O7S | 详情 | 供应商 |
| 62893-20-3 | 头孢哌酮钠; 7-[[(4-乙基-2,3-二氧代-1-哌嗪基)甲酰氨基](4-羟基苯基)乙酰氨基]-3-[(1-甲基-1H-四唑-5-基)硫 | Cefoperazone sodium; [6R-[6alpha,7beta(R*)]]-7-[[[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-car |  | C25H26N9NaO8S2 | 详情 | 供应商 |
| 62893-24-7 | 氧哌嗪酸; D-(-)-2-[(4-乙基-2,3-二氧代-1-哌嗪基)酰氨基]-2-(4-羟基苯基)乙酸 | (2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylamino]-2-(4-hydroxyphenyl)acetic acid; HO-EPCP |  | C15H17N3O6 | 详情 | 供应商 |
| 76610-84-9 | 头孢拉宗; (6R,7S)-7-((2R,3S)-2-(4-乙基-2,3-二氧代-1-哌嗪甲酰氨基)-3-羟基丁酰氨基)-7-甲氧基-3-(((1-甲 | Cefbuperazone |  | C22H29N9O9S2 | 详情 | 供应商 |
| 76648-01-6 | 头孢拉宗钠; (6R,7S)-7-[[(2R,3S)-2-[(4-乙基-2,3-二氧代哌嗪-1-甲酰)氨基]-3-羟基丁酰]氨基]-7-甲氧基-3-[( | Cefbuperazone sodium; Sodium (6R,7S)-7-[[(2R,3S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-3-hydroxybutanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-ca |  | C22H28N9NaO9S2 | 详情 | 供应商 |
| 140447-78-5 | 1-(N-Boc-氨乙基)哌嗪; 2-哌嗪-1-基乙基氨基甲酸叔丁酯 | 1-(2-N-Boc-Aminoethyl)piperazine; tert-Butyl 2-piperazin-1-ylethylcarbamate; (2-Piperazin-1-yl-ethyl)-carbamic acid tert-butyl ester |  | C11H23N3O2 | 详情 | 供应商 |
| 302962-49-8 | 达沙替尼; N-(2-氯-6-甲基苯基)-2-[[6-[4-(2-羟乙基)哌嗪-1-基]-2-甲基嘧啶-4-基]氨基]-1,3-噻唑-5-甲酰胺 | Dasatinib; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide |  | C22H26ClN7O2S | 详情 | 供应商 |
| 863127-77-9 | 达沙替尼; N-(2-氯-6-甲基苯基)-2-[[6-[4-(2-羟乙基)-1-哌嗪基]-2-甲基-4-嘧啶基]氨基]-5-噻唑甲酰胺(一水物 | Dasatinib monohydrate; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide monohydrate |  | C22H28ClN7O3S | 详情 | 供应商 |
| 31295-52-0 | 1-[2-[(2-氨乙基)[2-[(2-氨乙基)氨基]乙基]氨基]乙基]哌嗪 | 1-[2-[(2-aminoethyl)[2-[(2-aminoethyl)amino]ethyl] amino]ethyl]-Piperazine |  | C12H30N6 | 详情 | 供应商 |
| 31295-50-8 | 1-[2-[[2-[[2-[(2-氨乙基)氨基]乙基]氨基]乙基]氨基]乙基]哌嗪 | 1-[2-[[2-[[2-[(2-aminoethyl) amino]ethyl]amino] ethyl] amino]ethyl]-Piperazine |  | C12H30N6 | 详情 | 供应商 |
| 31295-53-1 | 1-[2-[[2-[双(2-氨乙基)氨基]乙基]氨基]乙基]哌嗪 | 1-[2-[[2-[bis(2-aminoethyl)amino]ethyl]amino]ethyl]-Piperazine |  | C12H30N6 | 详情 | 供应商 |
| 79868-75-0 | N-[(4-乙基-2,3-二氧代-1-哌嗪基)碳酰]-α-氨基对羟基苯乙酸; 2R-2[(4-乙基-2,3-双氧代哌嗪基)甲酰胺]? | N-((4-Ethyl-2,3-dioxo-1-piperazinyl)car-bonyl)-amino-p-hydroxyphenylacetic acid; N-(((4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)-4-hydroxybenzeneacetic acid; OH-EPCP; 2r-2-((4-ethyl-2,3-dioxypiperazyl)formamide)-p-hydroxy phenylacetic acid |  | C15H17N3O6 | 详情 | 供应商 |
| 31329-52-9 | N-[2-[(2-氨乙基)氨基]乙基]-1,4-二乙胺哌嗪 | N-[2-[(2-aminoethyl)amino]ethyl]-1,4-piperazine diethanamine; 1,4-Piperazinediethanamine,N-[2-[(2-aminoethyl)amino]ethyl]- (9CI); Piperazine,1-(2-aminoethyl)-4-[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]- (8CI) |  | C12H30N6 | 详情 | 供应商 |
| 3973-70-4 | 1-氨基-4-(2-羟乙基)哌嗪 | 1-Piperazineethanol,4-amino-; 1-Amino-4-(2-hydroxyethyl)piperazine; 2-(4-Aminopiperazin-1-yl)ethanol; 4-Amino-1-piperazineethanol; NSC 87954 |  | C6H15N3O | 详情 | 供应商 |
| 3644-18-6 | 1-(2-二甲基氨基乙基)哌嗪; 1-(2-二甲基氨基乙基)哌嗪; | 1-Piperazineethanamine,N,N-dimethyl-; Piperazine,1-[2-(dimethylamino)ethyl]- (6CI,8CI); 1-[2-(Dimethylamino)ethyl]piperazine; 4-[2-(Dimethylamino)ethyl]piperazine; Dimethyl[2-(piperazin-1-yl)ethyl]amine; N,N-Dimethyl-2-piperazin-1-ylethanamine; N,N-Dimethyl-N-[2-(piperazin-1-yl)ethyl]amine; N-(2-Dimethylaminoethyl)piperazine; N-[2-(N,N-Dimethylamino)ethyl]piperazine |  | C8H19N3 | 详情 | 供应商 |
| 1089283-49-7 | N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶 | GSK1904529A; GSK1904529A; GSK1904529A : IGF-IR, IGF-IIR inhibitor; N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide; GSK 4529 | 无 | C44H47F2N9O5S | 详情 | 供应商 |
| 1158838-45-9 | N-(2-氯苯基)-4-[[2-[[4-[2-(4-乙基-1-哌嗪基)-2-氧代乙基]苯基]氨基]-5-氟-4-嘧啶基]氨基]苯甲酰胺; N-(2-氯苯基)-4-[[2-[[4-[2-(4-乙基-1-哌嗪基)-2-氧代乙基]苯基]氨基]-5-氟-4-嘧啶基]氨基]苯甲酰胺 | N-(2-Chlorophenyl)-4-(2-(4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenylamino)-5-fluoropyrimidin-4-ylamino)benzamide; N-(2-Chlorophenyl)-4-(2-(4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenylamino)-5-fluoropyrimidin-4-ylamino)benzamide; N-(2-Chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]amino]-5-fluoro-4-pyrimidinyl]amino]benzamide; Aurora A Inhibitor I; BenzaMide, N-(2-chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]aMino]-5-fluoro-4-pyriMidinyl]aMino]-; N-(2-Chlorophenyl)-4-((2-((4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)-phenyl)amino)-5-fluoropyrimid |  | C31H31ClFN7O2 | 详情 | 供应商 |
| 872511-34-7 | 3-(2,6-二氯-3,5-二甲氧基苯基)-1-[6-[[4-(4-乙基哌嗪-1-基)苯基]氨基]嘧啶-4-基]-1-甲基脲; 3-(2,6-二氯-3,5-二甲氧基苯基)-1-[6-[[4-(4-乙基哌嗪-1-基)苯基]氨基]嘧啶-4-基]-1-甲基脲 | 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea; 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea; NVP-BGJ398; BGJ 398; BGJ-398; BGJ398 (NVP-BGJ398) |  | C26H31Cl2N7O3 | 详情 | 供应商 |
sitemap.xml